Associations between Comorbidities and Acute Exacerbation of Interstitial Lung Disease after Primary Lung Cancer Surgery

Authors: Kato, T., Miyoshi, S., Hamada, C., Sano, Y., Nogami, N., Yamaguchi, O., Hamaguchi, N.

Source: Acta medica Okayama. 77(3):301-310

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN633390159&indx=1&recIds=ETOCRN633390159

Pixel enlargement in high-speed camera image acquisition based on 3D sparse representations

Authors: Hirabayashi, A., Nogami, N., White, J., Condat, L.

Source: 2015 IEEE Workshop on Signal Processing Systems (SiPS) Signal Processing Systems (SiPS), 2015 IEEE Workshop on. :1-6 Oct, 2015

Relation: 2015 IEEE Workshop on Signal Processing Systems (SiPS)

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)

Authors: Gemba, K., Ikeda, G., Yasugi, M., Kurimoto, E., Nakano, K., Moritaka, T., Inoue, K., Miyoshi, S., Hamaguchi, N., Ito, R., Sano, Y., Takata, I., Mitani, A., Nishisaka, T., Shoda, H., Nishida, A., Tamamoto, S., Fujitaka, K., Masuda, T., Miyamoto, S., Hattori, N., Sugimoto, K., Fujii, S., Ueda, Y., Sakugawa, M., Fukamatsu, N., Ogata, Y., Bandoh, S., Kanaji, N., Takigawa, N., Yamane, H., Ochi, N., Honda, Y., Oka, M., Kittaka, M., Kubota, T., Yokoyama, A., Yokoyama, T., Sato, E., Shiota, Y., Horita, N., Kanematsu, T., Awaya, Y., Nakamasu, A., Murakami, I., Kuyama, S., Kudo, K., Tamura, T., Umeno, T., Morichika, D., Fujiwara, K., Sato, K., Harada, D., Nogami, N., Nishii, K., Fuchimoto, Y., Kishimoto, T., Kawai, H., Watanabe, K., Tokumo, K., Isobe, T., Tsubata, Y., Inoue, M., Ichikawa, H., Nishioka, Y., Hanibuchi, M., Goto, H., Sumikawa, T., Kodani, M., Suyama, H., Makino, H., Kinosita, N., Shimizu, E., Obata, H., Ikegami, H., Chikamori, K., Maeda, T., Kishino, T., Kamei, H., Ueoka, H., Kunihiro, Y., Kobayashi, T., Ueda, K., Hayashi, M., Kamiya, M., Murakami, J., Sato, A., Ichihara, E., Kubo, T., Ninomiya, T., Hirata, T., Minami, D., Kato, Y., Higo, H., Makimoto, G., Toyota, Y., Oda, N., Nakanishi, M., Kayatani, H., Senoo, S., Kano, H., Watanabe, H., Ando, T., Nakasuka, T., Hara, N., Itano, J., Nakashima, H., Tabata, M., Ninomiya, Kiichiro, Hata, Tae, Yoshioka, Hiroshige, Ohashi, Kadoaki, Bessho, Akihiro, Hosokawa, Shinobu, Ishikawa, Nobuhisa, Yamasaki, Masahiro, Shibayama, Takuo, Aoe, Keisuke, Kozuki, Toshiyuki, Harita, Shingo, Ueda, Yutaka, Murakami, Toshi, Fujimoto, Nobukazu, Yanai, Hiroyuki, Toyooka, Shinichi, Takata, Minoru, Hotta, Katsuyuki, Kiura, Katsuyuki

Source: In Chest August 2019 156(2):357-366

Previous Immune Checkpoint Inhibitor Treatment to Increase the Efficacy of Docetaxel and Ramucirumab Combination Chemotherapy

Authors: Harada, D., Takata, K., Mori, S., Kozuki, T., Takechi, Y., Moriki, S., Asakura, Y., Ohno, T., Nogami, N.

Source: Anticancer research. 39(9):4987-4994

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN621372978&indx=1&recIds=ETOCRN621372978

Therapeutic Outcomes of 15 Postoperative Bronchopleural Fistulas Including Seven Endoscopic Interventions

Authors: Ueno, T., Maki, Y., Sugimoto, R., Suehisa, H., Yamashita, M., Harada, D., Kozuki, T., Nogami, N.

Source: Acta medica Okayama. 73(4):325-332

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN621333068&indx=1&recIds=ETOCRN621333068

A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer

Authors: Yoshioka, H. ^*, Katakami, N., Okamoto, H., Iwamoto, Y., Seto, T., Takahashi, T., Sunaga, N., Kudoh, S., Chikamori, K., Harada, M., Tanaka, H., Saito, H., Saka, H., Takeda, K., Nogami, N., Masuda, N., Harada, T., Kitagawa, H., Horio, H., Yamanaka, T., Fukuoka, M., Yamamoto, N., Nakagawa, K.

Source: In Annals of Oncology February 2017 28(2):285-291

Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study

Authors: Suzuki, K., Yamanaka, T., Hashimoto, H., Shimada, Y., Arata, K., Matsui, R., Goto, K., Takiguchi, T., Ohyanagi, F., Kogure, Y., Nogami, N., Nakao, M., Takeda, K., Azuma, K., Nagase, S., Hayashi, T., Fujiwara, K., Shimada, T., Seki, N., Yamamoto, N. ^*

Source: In Annals of Oncology August 2016 27(8):1601-1606

Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)

Authors: Takeuchi, K. ^*, Togashi, Y., Kamihara, Y., Fukuyama, T., Yoshioka, H., Inoue, A., Katsuki, H., Kiura, K., Nakagawa, K., Seto, T., Maemondo, M., Hida, T., Harada, M., Ohe, Y., Nogami, N., Yamamoto, N., Nishio, M., Tamura, T.

Source: In Annals of Oncology January 2016 27(1):185-192

Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy

Authors: Tambo, Y., Hosomi, Y., Sakai, H., Nogami, N., Atagi, S., Sasaki, Y., Kato, T., Takahashi, T., Seto, T., Maemondo, M.

Source: INVESTIGATIONAL NEW DRUGS. 35(2):217-226

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN383377879&indx=1&recIds=ETOCRN383377879

Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non–Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol

Authors: Hotta, K., Sasaki, J., Saeki, S., Takigawa, N., Katsui, K., Takayama, K., Nogami, N., Shioyama, Y., Bessho, A., Kishimoto, J.

Source: CLINICAL LUNG CANCER. 17(1):75-79

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN381503640&indx=1&recIds=ETOCRN381503640

Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experience

Authors: Kudo, K., Hotta, K., Bessho, A., Nogami, N., Kozuki, T., Kuyama, S., Inoue, K., Harita, S., Okada, T., Gemba, K.

Source: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 77(5):1005-1009

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN377095686&indx=1&recIds=ETOCRN377095686

Phase II Trial of Gefitinib in Combination with Bevacizumab as First-Line Therapy for Advanced Non-Small Cell Lung Cancer with Activating EGFR Gene Mutations: The Okayama Lung

Authors: Ichihara, E., Hotta, K., Nogami, N., Kuyama, S., Kishino, D., Fujii, M., Kozuki, T., Tabata, M., Harada, D., Chikamori, K.

Source: JOURNAL OF THORACIC ONCOLOGY. 10(3):486-491

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN367552190&indx=1&recIds=ETOCRN367552190

Phase I dose-escalation study evaluating safety, tolerability and pharmacokinetics of MEDI-573, a dual IGF-I/II neutralizing antibody, in Japanese patients with advanced solid tumours

Authors: Iguchi, H., Nishina, T., Nogami, N., Kozuki, T., Yamagiwa, Y., Yagawa, K.

Source: INVESTIGATIONAL NEW DRUGS. 33(1):194-200

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN365859539&indx=1&recIds=ETOCRN365859539

A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0501

Authors: Nogami, N., Takigawa, N., Hotta, K., Segawa, Y., Kato, Y., Kozuki, T., Oze, I., Kishino, D., Aoe, K.

Source: LUNG CANCER -AMSTERDAM-. 87(2):141-147

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN365279455&indx=1&recIds=ETOCRN365279455

A phase II study of S-1 chemotherapy with concurrent thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0801

Authors: Aoe, K., Takigawa, N., Hotta, K., Maeda, T., Kishino, D., Nogami, N., Tabata, M., Harita, S., Okada, T.

Source: EUROPEAN JOURNAL OF CANCER -A-. 50(16):2783-2790

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN361834196&indx=1&recIds=ETOCRN361834196

Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience

Authors: Kato, Y., Hotta, K., Takigawa, N., Nogami, N., Kozuki, T., Sato, A., Ichihara, E., Kudo, K., Oze, I., Tabata, M.

Source: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 73(5):943-950

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN351900774&indx=1&recIds=ETOCRN351900774

A single-arm confirmatory study of amrubicin therapy in patients with refractory small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG0901)

Authors: Murakami, H., Yamamoto, N., Shibata, T., Takeda, K., Ichinose, Y., Ohe, Y., Takeda, Y., Kudoh, S., Atagi, S., Satouchi, M., Kiura, K., Nogami, N., Endo, M., Watanabe, H., Tamura, T.

Source: LUNG CANCER -AMSTERDAM-. 84(1):67-72

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN348604902&indx=1&recIds=ETOCRN348604902

LBA85Longitudinal circulating tumour DNA (ctDNA) monitoring for early detection of disease progression and resistance in advanced NSCLC in FLAURA

Authors: Gray, J E, Peled, N, Markovets, A, Nogami, N, Lee, J-S, Cho, B C, Chewaskulyong, B, Majem, M, Reungwetwattana, T, Vishwanathan, K, Todd, A, Rukazenkov, Y, Johnson, M, Barrett, C, Chmielecki, J, Hartmaier, R, Ramalingam, S S

Source: Annals of oncology. 30(5)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100097228270.0x000001&indx=1&recIds=ETOCvdc_100097228270.0x000001

1525PUpdated analysis of a phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404

Authors: Ninomiya, T, Nogami, N, Kozuki, T, Harada, D, Kubo, T, Ohashi, K, Kuyama, S, Kudo, K, Bessho, A, Fujimoto, N, Aoe, K, Shibayama, T, Minami, D, Sugimoto, K, Ochi, N, Takigawa, N, Hotta, K, Kiura, K

Source: Annals of oncology. 30(5)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100097242521.0x000001&indx=1&recIds=ETOCvdc_100097242521.0x000001

1566PRetrospective comparative study of the efficacy and safety in docetaxel and ramucirumab combination chemotherapy with or without previous immune checkpoint inhibitor treatment

Authors: Harada, D, Takata, K, Mori, S, Kozuki, T, Takechi, Y, Moriki, S, Asakura, Y, Ono, T, Nogami, N

Source: Annals of oncology. 30(5)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100097241890.0x000001&indx=1&recIds=ETOCvdc_100097241890.0x000001